Table 3.
SUV and total lesion glycolysis values in the primary tumors and metastatic lymph nodes
| Whole-body PET | Regional PET | |||
|---|---|---|---|---|
| Median | Range | Medianc | Range | |
| Primary tumor, SUV | ||||
| SUVmax | 11.1 | 6.3–20.8 | 13.5 (122 %) | 7.9–24.8 |
| SUVmean | 6.6 | 3.7–11.9 | 8.0 (121 %) | 4.6–13.8 |
| Nodal metastasis, SUV a | ||||
| SUVmax | 7.6 | 2.3–14.0 | 9.3 (122 %) | 3.3–15.0 |
| SUVmean | 5.3 | 1.8–9.4 | 6.1 (115 %) | 2.1–10.3 |
| Total lesion glycolysis b (primary tumor) | 51.1 | 9.7–765.2 | 91.5 (179 %) | 9.1–667.9 |
a One of them with SUVmax value among suspicious metastatic lymph nodes from each patient
b Calculated tumor volume with 40 % threshold of SUVmax value
c Increase from whole-body PET in parentheses refers to numerical value